Why the study?
Does aminophylline infusion improve hemodynamic parameters in patients with chronic obstructive pulmonary disease without cor pulmonale?
Does aminophylline infusion improve hemodynamic parameters in patients with chronic obstructive pulmonary disease without cor pulmonale?
Aminophylline infusion significantly reduces pulmonary and systemic pressures as well as vascular resistance in patients with COPD without cor pulmonale.
May support aminophylline for hemodynamics in COPD without cor pulmonale; Level 5 data leave open confirmation in trials.
Ten patients with chronic obstructive pulmonary disease without complicating cor pulmonale were studied by right and left heart catheterization. Hemodynamic and respiratory observations were made during a control period and during the infusion of 1 g of aminophylline. Aminophylline produced a significant reduction in mean pulmonary artery pressure from 19.7 mm Hg to 14.8 mm Hg, right ventricular end-diastolic pressure from 3.4 mm Hg to 1.4 mm Hg, left ventricular end-diastolic pressure from 6.5 mm Hg to 2.9 mm Hg, and the brachial artery mean pressure from 96.7 mm Hg to 86.2 mm Hg. The heart rate, oxygen consumption, and cardiac index increased. There was a significant fall in both peripheral and pulmonary vascular resistance. Evidence is presented to suggest that the decrease in pulmonary artery and systemic pressures was due to pulmonary and peripheral arteriolar dilatation.
No takes yet. Share an insight, caveat, or question.
Parker et al. (1967) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: